0.6029

22.82% 0.112

Applied Therapeutics Inc (APLT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.4909

Aprire:

$0.5

Volume 24 ore:

7.66M

Relative Volume:

3.42

Capitalizzazione di mercato:

$85.36M

Reddito:

Utile/perdita netta:

$-119.76M

Rapporto P/E:

-0.4466

EPS:

-1.35

Flusso di cassa netto:

$-55.17M

1 W Prestazione:

+50.84%

1M Prestazione:

+98.45%

6M Prestazione:

-93.06%

1 anno Prestazione:

-85.81%

Intervallo 1D:

$0.491

$0.638

Intervallo di 1 settimana:

$0.4151

$0.638

Portata 52W:

$0.295

$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Nome

Applied Therapeutics Inc

Settore

Healthcare (1170)

Industria

Biotechnology (671)

Telefono

212-220-9226

Indirizzo

545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY

Dipendente

Cinguettio

@Applied_Tx

Prossima data di guadagno

2025-03-31

Ultimi documenti SEC

APLT's Discussions on Twitter

Confronta APLT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
APLT Applied Therapeutics Inc	0.6029	56.59M	0	-119.76M	-55.17M	-1.35
ONC Beigene Ltd Adr	228.38	25.07B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	438.65	109.14B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.27	36.39M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	594.32	56.98B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	71.31	5.39B	0	-153.72M	-103.81M	-2.00

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-23	Downgrade	William Blair	Outperform → Mkt Perform
2024-12-02	Downgrade	UBS	Buy → Neutral
2024-11-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2024-07-31	Iniziato	William Blair	Outperform
2024-03-26	Iniziato	RBC Capital Mkts	Outperform
2024-02-22	Iniziato	Leerink Partners	Outperform
2022-01-04	Downgrade	Barclays	Overweight → Equal Weight
2021-08-27	Downgrade	Goldman	Neutral → Sell
2021-06-25	Ripresa	Goldman	Neutral
2020-10-08	Iniziato	Truist	Buy
2020-04-22	Iniziato	Goldman	Buy
2020-02-27	Iniziato	Barclays	Overweight
2019-06-10	Iniziato	Citigroup	Buy
2019-06-10	Iniziato	Cowen	Outperform
2019-06-10	Iniziato	Robert W. Baird	Outperform

Mostra tutto

Applied Therapeutics Inc Borsa (APLT) Ultime notizie

07:54 AM

Applied Therapeutics Presents Full 12-Month Clinical Results and - GuruFocus

07:54 AM

07:29 AM

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewswire

07:29 AM

07:28 AM

Breakthrough in CMT Treatment: New Clinical Data Shows First-Ever Disease Progression Slowing in 24-Month Study - Stock Titan

07:28 AM

May 17, 2025

Massive News for Apple Stock Investors! - The Globe and Mail

May 17, 2025

May 14, 2025

APLT: RBC Capital Reiterates Sector Perform Rating, Price Target Maintained | APLT Stock News - GuruFocus

May 14, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results | APLT Stock News - GuruFocus

May 14, 2025

Applied Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

Barclays PLC Sells 27,997 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 14, 2025

May 13, 2025

APLT Reports Financial Position and Advances in Govorestat Resea - GuruFocus

May 13, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results - Bluefield Daily Telegraph

May 13, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.

May 13, 2025

May 12, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 12, 2025

Alyeska Investment Group L.P. Boosts Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 12, 2025

Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT - ACCESS Newswire

May 12, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT - ACCESS Newswire

May 12, 2025

May 11, 2025

Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire

May 11, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 11, 2025

Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class ActionAPLT - ACCESS Newswire

May 11, 2025

Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

May 11, 2025

Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT - ACCESS Newswire

May 11, 2025

Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

May 11, 2025

May 10, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire

May 10, 2025

Applied Therapeutics Announces Acceptance of Late-Breaking Abstr - GuruFocus

May 10, 2025

May 09, 2025